Related Experiment Video
Updated: Feb 4, 2026

Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery
Published on: February 20, 2017
Pulmonary artery dilatation during normal pregnancy.
Karolina Golińska-Grzybała, Marcin Wiecheć, Bogdan Goliński
1Coronary Disease and Heart Failure Department, Medical College at Jagiellonian University and John Paul II Hospital, Kraków, Poland. ekonduracka@interia.eu.
Pulmonary artery diameter significantly increases during pregnancy in healthy women, associated with increased cardiac output and decreased systemic vascular resistance. These changes in pulmonary artery diameter typically resolve postpartum.
Area of Science:
- Cardiovascular physiology
- Obstetric medicine
- Pulmonary circulation
Background:
- Pregnancy induces significant cardiovascular alterations.
- Pulmonary artery behavior during gestation remains understudied.
- Understanding these changes is crucial for maternal and fetal health.
Purpose of the Study:
- To investigate pulmonary artery diameter (PAD) changes during pregnancy.
- To correlate PAD variations with left ventricular (LV) load and remodeling.
- To assess the relationship between PAD and systemic vascular resistance (SVR).
Main Methods:
- Prospective cohort study of 69 healthy pregnant women.
- Echocardiography and uterine artery ultrasonography performed at two prenatal visits (V1, V2) and one postpartum visit.
- Analysis of PAD, LV parameters, and SVR.
Main Results:
- Pulmonary artery diameter increased from 20.0 mm (V1) to 22.7 mm (V2) (p < 0.001), returning to 19.5 mm postpartum (p < 0.001 vs. V2).
- PAD positively correlated with LV end-diastolic diameter, LV end-systolic diameter, LV end-diastolic volume, LV mass, left atrial area, LV cardiac output, and aortic diameter.
- PAD showed a negative correlation with SVR (r = -0.307; p = 0.025) and pulsatility index (r = -0.318; p = 0.012).
Conclusions:
- Healthy pregnant women exhibit pulmonary artery dilatation without other echocardiographic abnormalities.
- These PAD changes are linked to increased volume load and reduced vascular resistance.
- Pulmonary artery diameter typically normalizes postpartum.
More Related Videos
07:02A Large Animal Model for Pulmonary Hypertension and Right Ventricular Failure: Left Pulmonary Artery Ligation and Progressive Main Pulmonary Artery Banding in Sheep
Published on: July 15, 2021
10:03Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Cardiomyopathy II: Dilated Cardiomyopathy
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Normal Distribution